Targeted Strategies for Today's Evolving Markets

MissionIR Blog

NexMed Inc. (NEXM) – Developing Patient Friendly Drugs

NexMed Inc. (NEXM:NASDAQ) is an innovative drug developer leveraging its proprietary NexACT transdermal drug delivery technology to produce a host of new medical treatments. The company’s drugs address a variety of health conditions such as nail fungus, sexual disorders and more.

NexMed offers large pharmaceutical companies the opportunity to incorporate NexACT into their existing drugs. This allows these companies to save considerably on R&D costs while developing new patient-friendly transdermal products and extending patent lifespans and brand equity.

NexMed’s drugs incorporate NexACT drug delivery technology, which offers several competitive advantages in the treatment of various illnesses. The NexACT penetration enhancers are designed to be structurally similar to, and biologically compatible with, the skin structure; they are also non-toxic, biodegradable, and enable drug candidates to efficiently overcome skin or mucosal membrane barriers. The company’s technology has applications in transdermal dosage forms like creams, ointments, lotions, gels, and sprays.

Let us hear your thoughts below:

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *